The Recall Desk
SevereFDA (Devices)·Z-0557-2016·Announced 2016-01-06

Elekta Recalls MOSAIQ Oncology System Due to Dosage Calculation Error

Elekta, Inc. is recalling 399 units of the MOSAIQ Oncology Information System because a software issue with age and weight data can cause incorrect drug dosages.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a risk of incorrect drug dosage, which is a significant injury risk.

Plain-English summary

Elekta, Inc. is recalling 399 units of the MOSAIQ Oncology Information System, a software system used to manage workflows for treatment planning and delivery in radiotherapy and chemotherapy. The recall is due to a software issue involving "Age Limit" and patient weight data items that can result in incorrect drug dosages.

The affected software includes versions 2.50 and higher. The units were distributed nationwide in the United States and in several international countries, including Australia, Canada, Germany, and the United Kingdom. The recall is classified as Class II by the FDA.

Healthcare facilities using the MOSAIQ system should contact Elekta, Inc. for instructions on how to resolve the issue and ensure patient safety.

The recalled product

Product
MOSAIQ Oncology Information System MOSAIQ is an oncology information system used to manage workflows for treatment planning and delivery. It supports information flow among healthcare facility personnel and can be used wherever radiotherapy and/or chemotherapy are prescribed.
Manufacturer
Elekta, Inc.
Affected units
399

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Versions 2.50 and higher

Distribution

Distributed nationwide across the United States.

The notice also names 45 states specifically: